Model Registration: A Call to Action
暂无分享,去创建一个
[1] Fiona Godlee,et al. All trials must be registered and the results published , 2013, BMJ.
[2] Joshua T. Cohen,et al. 30 Years of Pharmaceutical Cost-Utility Analyses , 2012, PharmacoEconomics.
[3] I. Leviton,et al. Registering clinical trials. , 2003, Journal of the American Medical Association (JAMA).
[4] William Hollingworth,et al. Model Transparency and Validation , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[5] J. Sacristán,et al. Publication bias in health economic studies. , 1997, PharmacoEconomics.
[6] John Hornberger. Computer modeling of diabetes and its complications: a report on the fifth mount hood challenge meeting. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[7] Jonathan Karnon,et al. Model Performance Evaluation (Validation and Calibration) in Model-based Studies of Therapeutic Interventions for Cardiovascular Diseases , 2013, Applied Health Economics and Health Policy.
[8] Helen Dakin,et al. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database , 2013, Health and Quality of Life Outcomes.
[9] Sean Ekins,et al. Time for Cooperation in Health Economics among the Modelling Community , 2012, PharmacoEconomics.
[10] J Chilcott,et al. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. , 2010, Health technology assessment.
[11] Sampson Christopher. Call for a model registry , 2014 .
[12] J. Mason,et al. Publication Bias in Clinical Trials and Economic Analyses , 1997, PharmacoEconomics.
[13] A E Ades,et al. Use of evidence in economic decision models: practical issues and methodological challenges. , 2007, Health economics.
[14] Andrew Briggs,et al. The “Hazards” of Extrapolating Survival Curves , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[15] R. Akehurst,et al. Benefits, Challenges and Potential Strategies of Open Source Health Economic Models , 2016, PharmacoEconomics.
[16] H. Riper,et al. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review , 2017, PharmacoEconomics - Open.
[17] J. Jaime Caro,et al. Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics , 2016, PharmacoEconomics.
[18] S. Goodacre,et al. Being economical with the truth: how to make your idea appear cost effective , 2002, Emergency medicine journal : EMJ.
[19] John Hornberger,et al. Computer Modeling of Diabetes and Its Complications , 2007, Diabetes Care.
[20] Mark Oppe,et al. The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration , 2015, PharmacoEconomics.
[21] N. Freemantle,et al. Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy , 2017, PharmacoEconomics.
[22] Keith Abrams,et al. Use of evidence in decision models: an appraisal of health technology assessments in the UK since 1997 , 2005, Journal of health services research & policy.
[23] Mihai Pop,et al. Use and mis-use of supplementary material in science publications , 2015, BMC Bioinformatics.
[24] John Brazier,et al. Development of the Scharr HUD (Health Utilities Database) , 2013 .
[25] S. Chick,et al. A taxonomy of model structures for economic evaluation of health technologies. , 2006, Health economics.
[26] David Moher,et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, International Journal of Technology Assessment in Health Care.
[27] Dyfrig A Hughes,et al. Development of a database of instruments for resource-use measurement: purpose, feasibility, and design. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[28] J. Caro,et al. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] G. Frederix,et al. Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer , 2016, PharmacoEconomics.
[30] Dan Greenberg,et al. Bias in published cost effectiveness studies: systematic review , 2006, BMJ : British Medical Journal.